March 3, 2009 - Boston Scientific Corp. today said it launched its TAXUS Liberté Paclitaxel-Eluting Coronary Stent System in Japan.
The product was approved on Jan. 28 by the Ministry of Health, Labor and Welfare, and reimbursement was granted yesterday by the National Health Insurance System.
